Showing posts with label Obama. Show all posts
Showing posts with label Obama. Show all posts

Monday, February 2, 2009

Obama Battles Big Pharma

Gianna Kali at Beyond Meds, has found this gem from the (UK) Independent.
I normally don't discuss politics or Big Pharma on this blog, but, this is important for any and all American readers to know.
“We will lower drug costs by allowing the importation of safe medicines from other developed countries, increasing the use of generic drugs in public programmes and taking on drug companies that block cheaper generic medicines from the market.” The wording of President Obama’s healthcare policy could not be clearer and should send a shiver through the boardroom of every major pharmaceutical group in the world.

For some time, the big players in the drugs market have faced a simple problem. Treatments that the likes of Pfizer, Novartis and GlaxoSmithKline (GSK) have spent years and millions of dollars developing are increasingly coming under threat from the generics companies, which invest nearly as much energy in challenging patents and developing cheaper alternatives. The established groups may consider the generics firms parasitical, but the likes of Barack Obama and the European Commission are tiring of the big beasts hiding behind patents ensuring that healthcare is more expensive to the ultimate user.

Gianna then sums it up much better than I can, so I will let her prose do the talking

Promising beginning. I didn’t buy that Obama was in pharma’s pocket just because he got more donations from individuals who worked for pharmaceutical companies then McCain did. So let’s hope this is the beginning of some saner policy that ends up policing big pharma in big ways.

Bob Fiddaman also reported on this and has this to say,
For some time, the big players in the drugs market have faced a simple problem. Treatments that the likes of Pfizer, Novartis and GlaxoSmithKline (GSK) have spent years and millions of dollars developing are increasingly coming under threat from the generics companies, which invest nearly as much energy in challenging patents and developing cheaper alternatives. The established groups may consider the generics firms parasitical, but the likes of Barack Obama and the European Commission are tiring of the big beasts hiding behind patents ensuring that healthcare is more expensive to the ultimate user.

Related Posts with Thumbnails